Suraksha Diagnostic IPO sees weak response, with 37% subscription; analysts advise avoiding due to high valuation and limited market presence.
SEBI’s new PMS framework could potentially double industry size over time: APMI Chairman Vikas Khemani
SEBI’s revised PMS framework introduces PRIM, expands investment options and lowers the entry threshold to ₹25 lakh. Industry leaders expect these changes to broaden PMS